← Back to Screener
Mangoceuticals, Inc. Common Stock (MGRX)
Price$0.36
Value ScoreD
Growth ScoreF
Momentum ScoreD
Favorite Metrics
Price vs S&P 500 (26W)-75.76%
Price vs S&P 500 (4W)-13.13%
VGM Score21.09
Market Capitalization$6.13M
All Metrics
Book Value / Share (Quarterly)$0.79
P/TBV (Annual)11.76x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)270.86%
Cash Flow / Share (Quarterly)$-0.29
Price vs S&P 500 (YTD)-59.91%
Gross Margin (TTM)52.42%
Net Profit Margin (TTM)-4632.82%
EPS (TTM)$-1.61
10-Day Avg Trading Volume0.56M
EPS Excl Extra (TTM)$-1.61
EPS (Annual)$-2.05
ROI (Annual)-135.80%
Gross Margin (Annual)54.91%
Cash / Share (Quarterly)$0.01
Revenue Growth QoQ (YoY)-37.92%
ROA (Last FY)-128.30%
Revenue Growth TTM (YoY)-18.88%
EBITD / Share (TTM)$-1.36
Operating Margin (TTM)-4604.64%
Cash Flow / Share (Annual)$-0.37
P/B Ratio0.45x
P/B Ratio (Quarterly)0.45x
EV / Revenue (TTM)14.36x
Net Interest Coverage (TTM)-198.43x
ROA (TTM)-113.12%
EPS Incl Extra (Annual)$-2.05
Current Ratio (Annual)1.74x
Quick Ratio (Quarterly)0.29x
3-Month Avg Trading Volume8.87M
52-Week Price Return-82.50%
Tangible BV / Share (Quarterly)$0.06
P/S Ratio (Annual)13.44x
Asset Turnover (Annual)0.03x
52-Week High$2.75
EPS Excl Extra (Annual)$-2.05
26-Week Price Return-67.84%
Quick Ratio (Annual)1.73x
13-Week Price Return-4.03%
Total Debt / Equity (Annual)0.00x
Current Ratio (Quarterly)0.29x
Enterprise Value$5.95M
Asset Turnover (TTM)0.02x
Pretax Margin (Annual)-4526.88%
Cash / Share (Annual)$0.09
3-Month Return Std Dev270.98%
ROE (Last FY)-135.80%
Net Interest Coverage (Annual)-133.83x
EPS Basic Excl Extra (Annual)$-2.05
Total Debt / Equity (Quarterly)0.00x
EPS Incl Extra (TTM)$-1.61
ROI (TTM)-119.39%
P/S Ratio (TTM)14.78x
Revenue / Share (Annual)$0.05
Tangible BV / Share (Annual)$0.06
Price vs S&P 500 (52W)-106.87%
Year-to-Date Return-51.76%
5-Day Price Return-15.04%
EPS Normalized (Annual)$-2.05
ROA (5Y Avg)-267.86%
Net Profit Margin (Annual)-4526.77%
Month-to-Date Return-16.98%
Cash Flow / Share (TTM)$-0.48
EBITD / Share (Annual)$-1.93
Operating Margin (Annual)-4504.18%
EPS Basic Excl Extra (TTM)$-1.61
P/TBV (Quarterly)11.76x
P/B Ratio (Annual)0.75x
Inventory Turnover (TTM)17.97x
Pretax Margin (TTM)-4632.91%
Book Value / Share (Annual)$0.96
Price vs S&P 500 (13W)-12.29%
Beta2.43x
Revenue / Share (TTM)$0.03
ROE (TTM)-120.70%
52-Week Low$0.16
vGradeD
gGradeF
mGradeD
vgmGradeD
Show chart for
Industry Peers — Health Services(17)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
MGRXMangoceuticals, Inc. Common Stock | D | F | D | $0.36 |
| DVADaVita Inc. | C | C | B | $192.16 |
| FMSFresenius Medical Care AG | A | D | C | $22.03 |
| SHCSotera Health Company Common Stock | D | B | C | $15.62 |
| PGNYProgyny, Inc. Common Stock | C | B | B | $25.86 |
| AGLagilon health, inc. | B | C | A | $96.85 |
| MCTACharming Medical Limited Class A Ordinary Shares | F | F | A | $29.36 |
| VMDViemed Healthcare, Inc. Common Shares | C | C | B | $9.97 |
| QIPTQuipt Home Medical Corp. Ordinary Shares | B | B | B | $0.00 |
| PARKPark Dental Partners, Inc. Common Stock | B | C | C | $18.96 |
| OAKUOak Woods Acquisition Corporation Class A Ordinary Shares | — | F | B | $0.00 |
About
Mangoceuticals Inc operates a men's health telemedicine platform that connects patients with licensed providers for remote consultations and prescription services. The company leverages an integrated pharmacy network to fulfill and distribute medications, including its proprietary erectile dysfunction products. This vertically integrated model combines telehealth services with direct-to-consumer pharmacy fulfillment.